FBXL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.929400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.361600E-01
Normal-vs-Stage2
4.189400E-01
Normal-vs-Stage3
1.111210E-01
Normal-vs-Stage4
3.567000E-01
Stage1-vs-Stage2
3.420500E-02
Stage1-vs-Stage3
1.112190E-01
Stage1-vs-Stage4
2.179200E-01
Stage2-vs-Stage3
3.638800E-01
Stage2-vs-Stage4
7.173400E-01
Stage3-vs-Stage4
6.472200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.171800E-01
Normal-vs-AfricanAmerican
7.219000E-01
Normal-vs-Asian
2.041000E-01
Caucasian-vs-AfricanAmerican
9.001400E-01
Caucasian-vs-Asian
2.275600E-01
AfricanAmerican-vs-Asian
3.553000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.599400E-01
Normal-vs-Female
7.518000E-01
Male-vs-Female
1.899440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.533800E-01
Normal-vs-Age(41-60Yrs)
9.768600E-01
Normal-vs-Age(61-80Yrs)
4.274200E-01
Normal-vs-Age(81-100Yrs)
3.680600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.874000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.934400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.576200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.260000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.112030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.551600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.784620E-01
Normal-vs-Daily Drinker
2.779800E-01
Normal-vs-Weekly Drinker
2.801600E-01
Normal-vs-Occasional Drinker
8.997000E-01
Normal-vs-Social Drinker
9.504400E-01
Non Drinker-vs-Daily Drinker
9.092600E-01
Non Drinker-vs-Weekly Drinker
8.560600E-01
Non Drinker-vs-Occasional Drinker
1.444790E-01
Non Drinker-vs-Social Drinker
1.561230E-01
Daily Drinker-vs-Weekly Drinker
9.469800E-01
Daily Drinker-vs-Occasional Drinker
1.708210E-01
Daily Drinker-vs-Social Drinker
1.843040E-01
Weekly Drinker-vs-Occasional Drinker
2.552000E-01
Weekly Drinker-vs-Social Drinker
2.093200E-01
Occasional Drinker-vs-Social Drinker
7.559600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.926400E-01
Normal-vs-Grade 2
6.669400E-01
Normal-vs-Grade 3
6.743200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.399200E-01
Grade 1-vs-Grade 3
3.260800E-01
Grade 1-vs-Grade 4
3.926400E-01
Grade 2-vs-Grade 3
8.930800E-01
Grade 2-vs-Grade 4
6.669400E-01
Grade 3-vs-Grade 4
6.743200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.013200E-01
Normal-vs-NonDiabetic
5.667200E-01
Diabetic-vs-NonDiabetic
1.588580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.494410E-01
Normal-vs-NoPancreatitis
5.070600E-01
Pancreatitis-vs-NoPancreatitis
4.946000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.388800E-01
Normal-vs-N1
4.248400E-01
N0-vs-N1
3.212600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.559000E-01
Normal-vs-TP53-NonMutant
9.863200E-01
TP53-Mutant-vs-TP53-NonMutant
2.011500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
